-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Only for medical professionals to read and refer to clinical information, 1s touch In the past 40 years, the prevalence of diabetes in adults in China has increased significantly
.
In 1980, the epidemiological data of 300,000 people in 14 provinces and cities across the country showed that the prevalence of diabetes was only 0.
67%, but in 2013 it had soared to 10.
4% [1]
.
So, has the prevalence of diabetes in my country "intensified" in recent years? How is the treatment of diabetes in our country? Screenshot of the source article Recently, Limin Wang et al.
published a paper in JAMA, the Journal of the American Medical Association, which investigated the prevalence and treatment status of diabetes and prediabetes in China from 2013 to 2018 [2] ]
.
Let's take a look at today's news! Want to see more of the previous issues of "Top Issue Highlights"? Come to the "Clinical Decision Assistant" service number to have a look! 1.
Click on the business card below to follow the official account of "Clinical Decision Assistant" 2.
Find "Top Journal Highlights" in the menu bar 3.
View the latest journals in various disciplines 4.
You can also click "Subscription Settings" 5.
Subscribe to the disciplines you care about The subject is pushed every day, and a new top issue is read every day! Such a useful tool, let's use it! References: [1] Guidelines for the Prevention and Treatment of Type 2 Diabetes in China (2017 Edition) [J].
Chinese Journal of Practical Internal Medicine, 2018, 38(04): 292-344.
DOI: 10.
19538/j.
nk2018040108.
[2] Wang L, Peng W, Zhao Z, et al.
Prevalence and Treatment of Diabetes in China, 2013-2018.
JAMA.
2021; 326(24):2498-2506.
doi:10.
1001/jama.
2021.
22208 Source: Clinical Decision Assistant Editor in charge of Jie Xiaoyao: Xiaodangdang medical community strives for the accuracy and reliability of its published content when it is approved, but does not make any commitment to the timeliness of the published content, and the accuracy and completeness of the cited materials (if any), etc.
and warranties, and disclaims any liability arising out of the outdated content, possible inaccuracies or incompleteness of the materials cited
.
Relevant parties are requested to check separately when adopting or using it as a basis for decision-making
.
.
In 1980, the epidemiological data of 300,000 people in 14 provinces and cities across the country showed that the prevalence of diabetes was only 0.
67%, but in 2013 it had soared to 10.
4% [1]
.
So, has the prevalence of diabetes in my country "intensified" in recent years? How is the treatment of diabetes in our country? Screenshot of the source article Recently, Limin Wang et al.
published a paper in JAMA, the Journal of the American Medical Association, which investigated the prevalence and treatment status of diabetes and prediabetes in China from 2013 to 2018 [2] ]
.
Let's take a look at today's news! Want to see more of the previous issues of "Top Issue Highlights"? Come to the "Clinical Decision Assistant" service number to have a look! 1.
Click on the business card below to follow the official account of "Clinical Decision Assistant" 2.
Find "Top Journal Highlights" in the menu bar 3.
View the latest journals in various disciplines 4.
You can also click "Subscription Settings" 5.
Subscribe to the disciplines you care about The subject is pushed every day, and a new top issue is read every day! Such a useful tool, let's use it! References: [1] Guidelines for the Prevention and Treatment of Type 2 Diabetes in China (2017 Edition) [J].
Chinese Journal of Practical Internal Medicine, 2018, 38(04): 292-344.
DOI: 10.
19538/j.
nk2018040108.
[2] Wang L, Peng W, Zhao Z, et al.
Prevalence and Treatment of Diabetes in China, 2013-2018.
JAMA.
2021; 326(24):2498-2506.
doi:10.
1001/jama.
2021.
22208 Source: Clinical Decision Assistant Editor in charge of Jie Xiaoyao: Xiaodangdang medical community strives for the accuracy and reliability of its published content when it is approved, but does not make any commitment to the timeliness of the published content, and the accuracy and completeness of the cited materials (if any), etc.
and warranties, and disclaims any liability arising out of the outdated content, possible inaccuracies or incompleteness of the materials cited
.
Relevant parties are requested to check separately when adopting or using it as a basis for decision-making
.
